1 | Warfarin | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [13] 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
2 | Warfarin 10 mg | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [2] 96 96, 97 |
3 | Warfarin Potassium | [2] Potassium Potassium, Warfarin | [4] D00564
D00564
,
D01280
,
D08403
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 88 88 |
4 | Warfarin Sodium | [1] Warfarin Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 49 49 |
5 | Warfarin+ Vitamin K | [2] Phylloquinone Phylloquinone, Warfarin | [4] D00148
D00148
,
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 46 46 |
6 | Warm compress prior to injection of glatiramer acetate | [2] Acetate Acetate, Glatiramer | [1] D04318
D04318
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 |
7 | Water | [1] Water Water | [1] D00001
D00001
| - | - | [23] 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
8 | Water exercises | [1] Water Water | [1] D00001
D00001
| - | - | [1] 46 46 |
9 | WATER FOR INJECTION | [1] Water Water | [1] D00001
D00001
| - | - | [1] 35 35 |
10 | Water for injections | [1] Water Water | [1] D00001
D00001
| - | - | [1] 299 299 |
11 | WATER FOR INJECTIONS, EP | [1] Water Water | [1] D00001
D00001
| - | - | [1] 299 299 |
12 | WAY-130799 | - | - | - | - | [1] 13 13 |
13 | WAY-177005 | - | - | - | - | [1] 46 46 |
14 | WD-1603 | - | - | - | - | [1] 6 6 |
15 | WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
16 | WD-1603 Carbidopa-Levodopa Extended-Release Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
17 | WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
18 | Weancare-domus | - | - | - | - | [1] 6 6 |
19 | Wellbutrin (bupropion) | [1] Bupropion Bupropion | [3] D00817
D00817
,
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 96 96 |
20 | WFI | - | - | - | - | [1] 96 96 |
21 | Whale blubber oil | - | - | - | - | [1] 46 46 |
22 | Wharton Jelly Mesenchymal stem cells | - | - | - | - | [1] 97 97 |
23 | Wharton's jelly derived mesenchymal stem cell | - | - | - | - | [1] 90 90 |
24 | WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS | - | - | - | - | [1] 36 36 |
25 | WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS | - | - | - | - | [1] 2 2 |
26 | Wheat | [1] Wheat Wheat | [1] D06902
D06902
| - | - | [3] 6 6, 98, 266 |
27 | Wheat bran | [2] Wheat Wheat, Wheat bran | [1] D06902
D06902
| - | - | [1] 6 6 |
28 | Whey protein | - | - | - | - | [2] 6 6, 96 |
29 | Whey Protein&Prebiotic Supplement | - | - | - | - | [1] 46 46 |
30 | White chocolate (0% cocoa) | [1] Cocoa Cocoa | - | - | - | [1] 6 6 |
31 | Whole blood sample | - | - | - | - | [1] 177 177 |
32 | Whole body planar SPECT imaging (15 Minutes post-injection) | - | - | - | - | [1] 46 46 |
33 | Whole body planar SPECT imaging (18-20 Hours post-injection) | - | - | - | - | [1] 46 46 |
34 | Whole body planar SPECT imaging (180 Minutes post-injection) | - | - | - | - | [1] 46 46 |
35 | Whole body planar SPECT imaging (60 Minutes post-injection) | - | - | - | - | [1] 46 46 |
36 | Whole body Protein turnover | - | - | - | - | [4] 19 19, 46, 96, 299 |
37 | Whole body Protein Turnover Study | - | - | - | - | [1] 299 299 |
38 | Whole Lung Lavage(WLL) | - | - | - | - | [1] 229 229 |
39 | WILATE | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
40 | Wilate 1000 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
41 | WILATE 1000 I.U. | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
42 | WILATE 450 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
43 | Wilate 500 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
44 | WILATE 500 I.U. | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
45 | WILATE 900 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
46 | WILATE® 450 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 |
47 | WILFACTIN | - | - | - | - | [1] 288 288 |
48 | Willfact | - | - | - | - | [1] 288 288 |
49 | Wiloctin | - | - | - | - | [1] 288 288 |
50 | Wilzin | [1] Zinc Zinc | - | - | - | [1] 171 171 |
51 | WIN-1001X | - | - | - | - | [1] 6 6 |
52 | With U-VANCO (vancomycin hydrochloride) | [1] Vancomycin Vancomycin | [2] D00212
D00212
,
D00926
| - | - | [1] 70 70 |
53 | Withania somnifera | - | - | - | - | [1] 2 2 |
54 | Without U-VANCO (vancomycin hydrochloride) | [1] Vancomycin Vancomycin | [2] D00212
D00212
,
D00926
| - | - | [1] 70 70 |
55 | WJ-MSCs | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 36 36 |
56 | WLL | - | - | - | - | [1] 229 229 |
57 | WM (Shentong Granules) | - | - | - | - | [1] 66 66 |
58 | WMT | - | - | - | - | [1] 96 96 |
59 | Wound topically irrigated with 500mg TXA | - | - | - | - | [1] 70 70 |
60 | Wristband physical activity monitor | [1] Methamidophos Methamidophos | - | - | - | [1] 13 13 |
61 | WTX101 | - | - | - | - | [1] 171 171 |
62 | Wuling Powder | - | - | - | - | [1] 6 6 |
63 | WVE-003 | - | - | - | - | [1] 8 8 |
64 | WVE-004 | - | - | - | - | [2] 2 2, 127 |
65 | WVE-120101 | - | - | - | - | [1] 8 8 |
66 | WVE-120102 | - | - | - | - | [1] 8 8 |
67 | WVE-210201 | - | - | - | - | [1] 113 113 |
68 | WVE-210201 (suvodirsen) | - | - | - | - | [1] 113 113 |
69 | WVE-N531 | - | - | - | - | [1] 113 113 |